U.S. Pediatric Home Healthcare (Rehabilitation Therapy Services, Skilled Nursing Services) Market Size, Share & Trends Analysis Report 2024-2030
July 11, 2024 11:01 ET
|
Research and Markets
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "U.S. Pediatric Home Healthcare Market Size, Share & Trends Analysis Report by Service (Rehabilitation Therapy Services, Skilled Nursing Services),...
United States Pediatrics KOLs Fair-Market Value Compensation Rates Report: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs)
July 10, 2024 05:23 ET
|
Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The "Fair-Market Value Compensation Rates for Pediatrics KOLs - United States" report has been added to ResearchAndMarkets.com's offering. Thought Leader...
NephroDI Therapeutics Announces Investment by Sound Bioventures to Accelerate Development of NDI-5001 as a Potential First-in-Class Therapy for Pediatric Orphan Kidney Disease
June 20, 2024 07:00 ET
|
NephroDI Therapeutics
New funding to take NDI-5001 into and through clinical proof of concept in Congenital Nephrogenic Diabetes Insipidus (NDI)New investment complements previously announced strategic corporate...
Sound Bioventures expands portfolio with new investment in US company NephroDI Therapeutics to accelerate development of NDI-5001 for pediatric orphan kidney disease
June 20, 2024 07:00 ET
|
Sound Bioventures
New funding will accelerate NephroDI’s asset, NDI-5001, into and through clinical proof of concept in Congenital Nephrogenic Diabetes Insipidus (NDI)New investment complements NephroDI’s previously...
Pediatric Electronic Medical Record (EMR) Software Market Analysis, 2018-2023 and 2024-2033 - Meta Platforms, Oracle, SAP, Cognizant Technology Solutions, and Koninklijke Philips Dominate the $3.83Bn Market
May 06, 2024 04:16 ET
|
Research and Markets
Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Pediatric Electronic Medical Record (EMR) Software Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global...
CareFirst BlueCross BlueShield and Children’s National Hospital Expand Access to Mental Health and Chronic Condition Support for Kids
May 01, 2024 13:01 ET
|
Children's National Hospital
Washington D.C., May 01, 2024 (GLOBE NEWSWIRE) -- Today, CareFirst BlueCross BlueShield (CareFirst), one of the largest not-for-profit healthcare organizations in the nation, and Children’s National...
Infectious Disease Connect Expands Telemedicine Services
April 16, 2024 09:15 ET
|
Infectious Disease Connect
PITTSBURGH, April 16, 2024 (GLOBE NEWSWIRE) -- Infectious Disease Connect (ID Connect), a leading infectious diseases telemedicine and software solutions company, has expanded its services to meet...
Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
March 18, 2024 07:05 ET
|
Sequel Med Tech
Sequel’s twiist™ automated insulin delivery system receives FDA 510(k) clearance. Significant advancements for people with people with Type 1 diabetes.
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
March 13, 2024 07:55 ET
|
Catalyst Pharmaceuticals, Inc.
AGAMREE® (vamorolone) a Novel Alternative Corticosteroid with Demonstrated Properties in Maintaining Efficacy and a Well-Tolerated Side Effect Profile Available in the U.S. by Prescription for...
Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
March 12, 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, March 12, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that the United States Patent and Trademark Office...